N-(4-Fluoro-2-methoxy-5-nitrophenyl)-4-(1-methyl-1H-indol-3-yl)-2-pyrimidinamine

We are N-(4-Fluoro-2-methoxy-5-nitrophenyl)-4-(1-methyl-1H-indol-3-yl)-2-pyrimidinamine CAS:1421372-94-2 manufacturer and supplier in China, Pls send inquiry of to info@nbinno.com of visit www.nbinno.com our official website should you have any interests

Chemical Name:N-(4-Fluoro-2-methoxy-5-nitrophenyl)-4-(1-methyl-1H-indol-3-yl)-2-pyrimidinamine
CAS.NO:1421372-94-2
Synonyms:N-(4-Fluoro-2-methoxy-5-nitrophenyl)-4-(1-methyl-1H-indol-3-yl)-2-pyrimidinamine
N-(4-Fluoro-2-methoxy-5-nitrophenyl)-4-(1-methyl-1H-indol-3-yl)-2-pyrimidinamine
AZD9291 Intermediate 2
2-Pyrimidinamine, N-(4-fluoro-2-methoxy-5-nitrophenyl)-4-(1-methyl-1H-indol-3-yl)-
N-(4-fluoro-2-Methoxy-5-nitrophenyl)-4-(1-Methylindol-3-yl) pyriMidin-2-aMine
N-(4-fluoro-2-methoxy-5-nitrophenyl)-4-(1-methyl-1H-indol-3-yl)pyrimidin-2-amine
 
Physical and Chemical Properties:
Density 1.4±0.1 g/cm3
Boiling Point 639.3±65.0 °C at 760 mmHg
Molecular Formula C20H16FN5O3
Molecular Weight 393.371
Flash Point 340.4±34.3 °C
 
Specification:
Appearance:Off-white powder
Assay:≥98.0%
 
Packing:25 kg/drum, can also be packaged according to customer requirements
Storage:Store in a cool, ventilated place
Application:Intermediate of AZD9291.

N-(4-Fluoro-2-methoxy-5-nitrophenyl)-4-(1-methyl-1H-indol-3-yl)-2-pyrimidinamine


Related News: Pharmaceutical intermediates and APIs belong to the fine chemical industry.5-acetil-2-hidroxibenzamida CAS:40187-51-7 A Phase 1/2 trial of the combination therapy has been fully enrolled, and the preliminary efficacy and safety data was presented at The American Society of Hematology (ASH) Annual Meeting in December 2018.O-(6-Chlorobenzotriazol-1-yl)-N,N,N',N'-tetramethyluronium Tetrafluoroborate In addition, due to environmental constraints, Yancheng Lianhua’s first pesticide project ANBE was put into operation at a slower pace than expected, and other pesticide projects were also put into operation.(3S,4S)-1-benzyl-N,4-dimethylpiperidin-3-amine dihydrochloride CAS:477600-68-3 Onconova Therapeutics, Inc. and Inceptua Medicines Access (a business unit of the Inceptua Group) recently announced they have entered into a collaboration to make available intravenous rigosertib via a Pre-approval Access Program in selected countries around the world.The government is leveraging its large patient population to push non-domestic drugs companies to cut prices to their lowest level globally.

Related Products
Product Name
2-Trifluoromethyl-5-bromopyridine View Details
quinoxalin-2-ol View Details
5-[2-(dibenzylamino)acetyl]-2-hydroxybenzamide View Details
4-Cloromethyl-5-methyl-1,3-dioxol-2-one manufacturer Fmoc-N-methyl-L-leucine manufacturer 3-Chlorophenylboronic acid manufacturer 2′,3′-Dideoxyguanosine manufacturer Hexadecyltrimethoxysilane manufacturer